Literature DB >> 28643632

Severe Vaso-Occlusive Episodes Associated with Use of Systemic Corticosteroids in Patients with Sickle Cell Disease.

Deepika S Darbari1, Ros S Fasano2, Caterina P Minniti2, Oswald O Castro3, Victor R Gordeuk3, James G Taylor4, Jeffre Y Rehm5.   

Abstract

Patients with sickle cell disease (SCD) are occasionally prescribed systemic corticosteroids to treat steroid-responsive conditions. Additionally, use of systemic corticosteroids for sickle cell pain episodes and acute chest syndrome is under investigation. We report 4 patients with SCD who developed severe vaso-occlusive events following the administration of systemic steroids. We also review similar cases from the literature and suggest measures for reducing the potential risk associated with use of systemic corticosteroids in this group of patients. We conclude that corticosteroids should be used with caution in patients with SCD.
© 2008 National Medical Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adverse events; bone; corticosteroids; sickle cell anemia; vaso-occlusion

Year:  2008        PMID： 28643632      PMCID： PMC5577928          DOI： 10.1016/S0027-9684(15)31410-3

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


  10 in total

1.  Fatal sickle cell crisis after granulocyte colony-stimulating factor administration.

Authors:  B K Adler; D E Salzman; M H Carabasi; W P Vaughan; V V Reddy; J T Prchal
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

2.  Sickling crisis, fat embolism, and coma after steroids.

Authors:  J C Huang; R Gay; S L Khella
Journal:  Lancet       Date:  1994-10-01       Impact factor: 79.321

3.  Steroid treatment in children with sickle-cell disease.

Authors:  Sonia Couillard; Malika Benkerrou; Robert Girot; Valentine Brousse; Alicia Ferster; Brigitte Bader-Meunier
Journal:  Haematologica       Date:  2007-03       Impact factor: 9.941

4.  Fat embolism syndrome associated with asthma and sickle cell-beta(+)-thalassemia.

Authors:  K Johnson; J F Stastny; D L Rucknagel
Journal:  Am J Hematol       Date:  1994-08       Impact factor: 10.047

5.  Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids.

Authors:  John J Strouse; Monica L Hulbert; Michael R DeBaun; Lori C Jordan; James F Casella
Journal:  Pediatrics       Date:  2006-11       Impact factor: 7.124

6.  Fat embolism in sickle cell disease. Report of a case with brief review of the literature.

Authors:  M P Shapiro; J A Hayes
Journal:  Arch Intern Med       Date:  1984-01

7.  Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease.

Authors:  J C Bernini; Z R Rogers; E S Sandler; J S Reisch; C T Quinn; G R Buchanan
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

8.  Sickle cell crisis following intraarticular steroid therapy for rheumatoid arthritis.

Authors:  D D Gladman; C Bombardier
Journal:  Arthritis Rheum       Date:  1987-09

9.  Nontraumatic fat embolism syndrome in sickle cell anemia.

Authors:  D P Horton; D M Ferriero; W C Mentzer
Journal:  Pediatr Neurol       Date:  1995-01       Impact factor: 3.372

10.  Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease.

Authors:  John J Strouse; Clifford M Takemoto; Jeffrey R Keefer; Gregory J Kato; James F Casella
Journal:  Pediatr Blood Cancer       Date:  2008-05       Impact factor: 3.167
  10 in total
  24 in total

1.  Depressive symptoms and sickle cell pain: The moderating role of internalized stigma.

Authors:  Breanna M Holloway; Lakeya S McGill; Shawn M Bediako
Journal:  Stigma Health       Date:  2017-11

Review 2.  Pulmonary complications of sickle cell disease.

Authors:  Andrew C Miller; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2012-03-23       Impact factor: 21.405

3.  Prevalence and Clinical Characteristics of Rheumatoid Arthritis in an Inner City Population with Sickle Cell Disease.

Authors:  Isabel M McFarlane; David J Ozeri; Joshy Pathiparampil; Randolph Sanchez; Justin Levinson; Odeth Barrett-Campbell; Carla Saladini-Aponte; Beatrix Boisette; Moro Salifu
Journal:  Rheumatology (Sunnyvale)       Date:  2017-04-28

4.  Recurrent, severe wheezing is associated with morbidity and mortality in adults with sickle cell disease.

Authors:  Robyn T Cohen; Anusha Madadi; Morey A Blinder; Michael R DeBaun; Robert C Strunk; Joshua J Field
Journal:  Am J Hematol       Date:  2011-08-02       Impact factor: 10.047

5.  The Gut Microbiome Regulates Psychological-Stress-Induced Inflammation.

Authors:  Chunliang Xu; Sung Kyun Lee; Dachuan Zhang; Paul S Frenette
Journal:  Immunity       Date:  2020-07-30       Impact factor: 31.745

6.  Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission.

Authors:  Amy Sobota; Dionne A Graham; Matthew M Heeney; Ellis J Neufeld
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

Review 7.  Pharmacotherapy in sickle cell disease--state of the art and future prospects.

Authors:  Jane Hankins; Banu Aygun
Journal:  Br J Haematol       Date:  2009-02-17       Impact factor: 6.998

Review 8.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

Review 9.  Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.

Authors:  Karina Yazdanbakhsh; Russell E Ware; France Noizat-Pirenne
Journal:  Blood       Date:  2012-05-04       Impact factor: 22.113

Review 10.  Chronic Pulmonary Complications of Sickle Cell Disease.

Authors:  Alem Mehari; Elizabeth S Klings
Journal:  Chest       Date:  2016-01-13       Impact factor: 9.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.